Arthneeti

Chemfab Alkalis Q2 FY27 Share Price & Earnings Call Analysis

₹302.05+1.43% today
Market cap
₹434 Cr
ROE
-2.49%
Price to sales
1.49
Debt to equity
0.38
52W high / low
₹590 / ₹291
Sales growth (5Y)
11.46%
EBITDA margin
9.47%
Net profit margin
-3.02%
Promoter holding
72.13%
Sales (last year)
₹292 Cr

Incorproated in 2009, Chemfab Alkalis Ltd manufactures basic inorganic chemicals and PVCO pipes[1]

Potential multibaggers · Q2 FY27

Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Strong growth
    3
See all potential multibaggersWhere does Chemfab Alkalis rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Chemicals & Petrochemicals companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 0–2%₹234 Cr3.0
240%+Flat₹3,888 Cr48.5
340%+Flat₹3,514 Cr4.3
440%+Flat₹180 Cr11.9
540%+Flat₹138 Cr15.1
620–40%Up 2%+₹1.70L Cr85.4

Sign up free to see every company in the sector ranking and track Chemfab Alkalis.

Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals ranking

Financials of Chemfab Alkalis

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Shareholder Pattern

Chemfab Alkalis

Shareholding breakup across reporting periods.

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters +72.88%72.88%72.88%72.63%72.56%72.18%72.18%72.18%72.14%72.14%72.14%72.14%
FIIs +0.29%0.35%0.27%0.11%0.03%0.03%0.01%0.00%0.08%0.04%0.04%0.04%
DIIs +0.07%0.07%0.07%0.07%0.27%0.27%0.27%0.27%0.22%0.10%0.07%0.07%
Government +0.03%0.03%0.00%0.00%0.00%0.00%0.00%0.06%0.06%0.06%0.06%0.00%
Public +26.73%26.65%26.77%27.20%27.12%27.50%27.53%27.48%27.49%27.64%27.69%27.76%
No. of Shareholders11,74512,62411,70412,53612,43011,87711,58611,58611,37010,94210,65010,485

Financials of Chemfab Alkalis

Quarterly Results

Quarter-by-quarter operating performance

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales +79.5886.3382.3176.5381.9083.6292.3291.5476.5668.1474.7873.1675.61
Expenses +68.7071.1369.9868.2071.7571.7178.9880.2471.1066.2166.2663.0368.57
Operating Profit10.8815.2012.338.3310.1511.9113.3411.305.461.938.5210.137.04
OPM %13.67%17.61%14.98%10.88%12.39%14.24%14.45%12.34%7.13%2.83%11.39%13.85%9.31%
Other Income +1.461.511.902.590.602.55-8.511.361.762.772.802.080.37
Interest0.060.430.410.941.221.201.571.571.942.032.142.212.46
Depreciation5.625.455.867.318.809.6210.616.396.617.477.957.787.90
Profit before tax6.6610.837.962.670.733.64-7.354.70-1.33-4.801.232.22-2.95
Tax %35.44%34.35%32.04%66.67%172.60%48.08%25.03%45.74%51.13%-7.08%60.16%-158.11%-28.14%
Net Profit +4.307.105.410.90-0.531.88-9.192.55-2.01-4.450.485.73-2.11
EPS in Rs3.034.993.800.63-0.371.32-6.401.78-1.40-3.100.333.99-1.47

Financials of Chemfab Alkalis

Profit & Loss

Annual income statement trend

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales +205181272331327334311292
Expenses +149157215221273290284264
Operating Profit55245711155442728
OPM %27%13%21%33%17%13%9%9%
Other Income +-01629-398
Interest43112689
Depreciation2520222322362831
Profit before tax272398939-0-0-4
Tax %5%500%26%28%33%2,210%1,615%
Net Profit +25-8296526-7-3-0
EPS in Rs18.26-5.7820.3445.5418.50-4.83-2.39-0.25
Dividend Payout %7%0%6%3%7%-26%-52%

Financials of Chemfab Alkalis

Balance Sheet

Capital structure and asset base

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital1414141414141414
Reserves262253284347373366361363
Borrowings +4332922084126144
Other Liabilities +3036464893577661
Total Liabilities348335352412500522577582
Fixed Assets +195202194192247317387380
CWIP35383174363133
Investments12431685161415
Other Assets +118105119121174152146155
Total Assets348335352412500522577582

Financials of Chemfab Alkalis

Cash Flows

Operating, investing and financing cash movement

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +54455593314038
Cash from Investing Activity +-58-6-21-48-110-86-81
Cash from Financing Activity +3-16-25-9165931
Net Cash Flow-123936-6213-12
Free Cash Flow-4383540-60-71-38
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit110%157%107%97%74%104%142%

Financials of Chemfab Alkalis

Ratios

Working capital efficiency and return ratios

Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days17312924242328
Inventory Days847954896010092
Days Payable16515492145101118111
Cash Conversion Cycle-63-45-9-32-1849
Working Capital Days-21557-2428-1
ROCE %2%13%28%10%3%1%
10out of 100

Momentum score · price trend

10 out of 100 — Cooling

Over the past year its share price has done worse than most of the stocks we track.

PeriodShare price changeBetter than … of 1,910 stocks
Last 12 months−47.2%4%
Last 6 months−2.0%26%
Last 3 months−6.6%44%

The price is 71% below its all-time high of ₹1,132.85 (1 Nov 2024). Stocks more than 20% below their peak have their score halved, so 21 became 10.

How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Chemfab Alkalis: 0.4 × 4 + 0.4 × 26 + 0.2 × 44 = 21, halved to 10 because the price is more than 20% below its all-time high.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 1 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Continue your research

What Chemfab Alkalis's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • J.G.Chemicals (Q2 FY27)

    Q2 FY27 Revenue from Operations: ₹3,610 million, up 63.9% YoY (₹2,203 million in Q2 FY26) (Page 23) . Key investor presentation takeaways from J.G.Chemicals Ltd

  • Lords Chloro (Q2 FY27)

    115.40 Crore, up 17.34% YoY from Rs. Key investor presentation takeaways from Lords Chloro Alkali Ltd's Q2 FY27 investor presentation — and how it ranks against

  • Camlin Fine (Q2 FY27)

    Q2 FY27 revenue: Rs 4,915 mn, up 9.15% YoY from Rs 4,503 mn in Q2 FY26 (Page 6, 9) . Key investor presentation takeaways from Camlin Fine Sciences Ltd's Q2 FY27

  • Gujarat Fluoroch (Q2 FY27)

    Consolidated Q2FY27 revenue: ₹1,760 crore, up 45% YoY (Q2FY26: ₹1,210 crore). Key investor presentation takeaways from Gujarat Fluorochemicals Ltd's Q2 FY27 inv

Compare:vs Solar Industriesvs Pidilite Industriesvs SRF